Earnings Feed
Start Free
Horizon Therapeutics Public Ltd Co·4

Mar 6, 4:48 PM ET

DesJardin Michael A. 4

4 · Horizon Therapeutics Public Ltd Co · Filed Mar 6, 2023

Insider Transaction Report

Form 4
Period: 2023-03-02
Horizon Therapeutics Public Ltd CoHZNP
DesJardin Michael A.
EVP, Technical Operations
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2023-03-02$14.93/sh+3,629$54,181→ 125,815 total
  • Exercise/Conversion

    Ordinary Shares

    2023-03-02$17.19/sh+743$12,772→ 126,558 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-03-02−3,629→ 0 total
    Exercise: $14.93Exp: 2026-12-14→ Ordinary Shares (3,629 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-03-02−743→ 0 total
    Exercise: $17.19Exp: 2027-02-20→ Ordinary Shares (743 underlying)
Footnotes (1)
  • [F1]The stock option is fully vested.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION